Author Question: A pregnant patient is 1 week post-term and will receive intravenous oxytocin. Which will the nurse ... (Read 143 times)

mpobi80

  • Hero Member
  • *****
  • Posts: 519
A pregnant patient is 1 week post-term and will receive intravenous oxytocin. Which will the nurse evaluate before starting the infusion? (Select all that apply.)
 
  a. Cervical ripening
  b. Fetal monitoring
  c. Renal function
  d. Respiratory function
  e. Uterine activity

Question 2

A nurse provides teaching to a woman who is taking tranexamic acid (Lysteda) for menorrhagia. Which statement by the patient indicates a need for further teaching?
 
  a. I may experience back pain or muscle cramps while taking this drug.
  b. I may take two tablets 3 times daily for up to 5 days with each period.
  c. I should take an oral contraceptive to prevent pregnancy while taking this drug.
  d. I should take this medication with food to improve absorption of the drug.



popopong

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

ANS: A, B, E
Before labor can be safely induced, cervical ripening must occur. Baseline data must include full maternal and fetal status. Maternal renal function and respiratory function are not part of the baseline assessment.

Answer to Question 2

ANS: C
The greatest concern with tranexamic acid (TA) is venous or arterial thrombosis. Women taking TA should not take oral contraceptives, which would increase the risk of thrombosis. Back pain and muscle cramps are known adverse effects. Women may take up to two tablets 3 times a day for up to 5 days with each period. The medication can be taken with or without food, but bioavailability increases in the presence of food.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Malaria was not eliminated in the United States until 1951. The term eliminated means that no new cases arise in a country for 3 years.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

For a complete list of videos, visit our video library